Company / FCF Margin
PULSE BIOSCIENCES, INC. FCF Margin History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-15553.4%
FY2025
5-year range
-15553.4% / -3845.8%
FY2021-FY2025
Trend
-
vs FY2024
Sector context
#145 of 145
Health Care
What the data says
Among 145 Health Care companies, PULSE BIOSCIENCES, INC. is in the bottom 0% for fcf margin. Declined from -6773.4% to -15553.4% over the past 3 years.
Based on SEC 10-K filings.
-15553.4% in FY2025 with a 3-year CAGR of -8780.0%.
Declined from -6773.4% to -15553.4% over the past 3 years.
Health Care sector context is included.
FCF Margin over time
Growth rates
- 3-Year Change
- -8780.0pp
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
Bottom 0% in Health CareTop 100% of 145This company -15553.4% Sector average -207.5%
▼
-7394.9% below sector average
Key checks
Key Insights
- Currently 15345.9pp below the Health Care sector average.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.66 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -15553.4% | - |
| FY2024 | - | - |
| FY2023 | -6773.4% | +0.0% |
| FY2022 | -6773.4% | -76.1% |
| FY2021 | -3845.8% | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026